Ph+ ALL
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL (NCT04554459) | Institute of Hematology and Blood Transfusion, Czech Republic | 2021-02-16 |
| Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium (NCT03678454) | Incyte Biosciences Benelux | 2017-02-03 |
| Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01028716) | Fred Hutchinson Cancer Center | 2010-05-19 |
Track Ph+ ALL automatically
Every clearance here is in the API, with alerts when new ones post.